{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T01:29:18Z","timestamp":1743902958714,"version":"3.37.3"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Israel Cancer Research Fund of Montreal"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,8]]},"DOI":"10.1093\/jnci\/djae057","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T10:09:14Z","timestamp":1711015754000},"page":"633-634","source":"Crossref","is-referenced-by-count":1,"title":["Fertility-preserving treatments for endometrial intraepithelial neoplasia: the known unknowns"],"prefix":"10.1093","volume":"116","author":[{"given":"Gabriel","family":"Levin","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Jewish General Hospital, McGill University , Montreal, QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6227-6369","authenticated-orcid":false,"given":"Walter H","family":"Gotlieb","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Jewish General Hospital, McGill University , Montreal, QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"issue":"5","key":"2024050807534472400_djae057-B1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/jnci\/djae023","article-title":"Levonorgestrel-releasing intrauterine device therapy versus oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis","volume":"116","author":"Suzuki","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2024050807534472400_djae057-B2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/1471-0528.14385","article-title":"Premenopausal abnormal uterine bleeding and risk of endometrial cancer","volume":"124","author":"Pennant","year":"2017","journal-title":"BJOG"},{"issue":"4","key":"2024050807534472400_djae057-B3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.semdp.2010.09.007","article-title":"Endometrial intraepithelial neoplasia","volume":"27","author":"Jarboe","year":"2010","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"2024050807534472400_djae057-B4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/AOG.0000000000005297","article-title":"Management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia: ACOG Clinical Consensus No. 5","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"2024050807534472400_djae057-B5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM196102022640503","article-title":"Progestational agents in the treatment of carcinoma of the endometrium","volume":"264","author":"Kelley","year":"1961","journal-title":"N Engl J Med"},{"issue":"9","key":"2024050807534472400_djae057-B6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/cncr.30529","article-title":"Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?","volume":"123","author":"Greenwald","year":"2017","journal-title":"Cancer"},{"issue":"5","key":"2024050807534472400_djae057-B7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1067\/mob.2003.346","article-title":"Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system","volume":"188","author":"Wildemeersch","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2024050807534472400_djae057-B8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mob.2002.122130","article-title":"Intrauterine progesterone treatment of early endometrial cancer","volume":"186","author":"Montz","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"232","key":"2024050807534472400_djae057-B9","first-page":"1","article-title":"Mean age of mothers is on the rise: United States, 2000-2014","author":"Mathews","year":"2016","journal-title":"NCHS Data Brief"},{"issue":"2","key":"2024050807534472400_djae057-B10","doi-asserted-by":"crossref","first-page":"E439","DOI":"10.9778\/cmajo.20210205","article-title":"Trends in obesity across Canada from 2005 to 2018: a consecutive cross-sectional population-based study","volume":"10","author":"Lytvyak","year":"2022","journal-title":"CMAJ Open"},{"issue":"4","key":"2024050807534472400_djae057-B11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1471-0528.12499","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial","volume":"121","author":"Orbo","year":"2014","journal-title":"BJOG"},{"issue":"3","key":"2024050807534472400_djae057-B12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertil Steril"},{"issue":"12","key":"2024050807534472400_djae057-B13","first-page":"ED000095","article-title":"The emerging epidemic of endometrial cancer: time to take action","volume":"2014","author":"Crosbie","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"10023","key":"2024050807534472400_djae057-B14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"2024050807534472400_djae057-B15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10552-017-0908-9","article-title":"Association of endometrial hyperplasia and cancer with a history of gestational diabetes","volume":"28","author":"Wartko","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"11","key":"2024050807534472400_djae057-B16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/09513590.2019.1624716","article-title":"Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment","volume":"35","author":"Raffone","year":"2019","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2024050807534472400_djae057-B17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/AOG.0000000000005124","article-title":"Systemic progestins and progestin-releasing intrauterine device therapy for premenopausal patients with endometrial intraepithelial neoplasia","volume":"141","author":"Suzuki","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2024050807534472400_djae057-B18","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2019.12.273","article-title":"Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy","volume":"223","author":"Mandelbaum","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2024050807534472400_djae057-B19","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1245\/s10434-016-5699-9","article-title":"Levonorgestrel-releasing intrauterine systems versus oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: a meta-analysis","volume":"24","author":"Yuk","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2024050807534472400_djae057-B20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/humrep\/det049","article-title":"Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum Reprod"},{"issue":"12","key":"2024050807534472400_djae057-B21","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.32822","article-title":"Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma","volume":"126","author":"Russo","year":"2020","journal-title":"Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djae057\/57035779\/djae057.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/5\/633\/57420831\/djae057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/5\/633\/57420831\/djae057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T20:13:59Z","timestamp":1731528839000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/116\/5\/633\/7632612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,20]]},"published-print":{"date-parts":[[2024,5,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djae057","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"type":"print","value":"0027-8874"},{"type":"electronic","value":"1460-2105"}],"subject":[],"published-other":{"date-parts":[[2024,5,1]]},"published":{"date-parts":[[2024,3,20]]}}}